» Articles » PMID: 12485617

Alpha(1)-acid Glycoprotein: an Acute Phase Protein with Inflammatory and Immunomodulating Properties

Overview
Date 2002 Dec 18
PMID 12485617
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

alpha(1)-Acid glycoprotein (AGP) is a protein with a molecular weight of 41-43 kDa and is heavily glycosylated (45%). Due to the presence of sialic acids, it is negatively charged (pI=2.7-3.2). AGP is an acute phase protein in all mammals investigated to date. The serum concentration of AGP rises several fold during an acute phase response, the systemic answer to a local inflammatory stimulus. Also, its glycosylation pattern can change depending on the type of inflammation. The biological function of this protein is not clear. A number of activities on different type of blood cells have been described. In vivo, AGP clearly has protective effects in several models of inflammation. Here we review the data supporting an anti-inflammatory and immunomodulating role of AGP.

Citing Articles

The Role of Acute Phase Reactants, Including α1-Acid Glycoprotein, in Predicting Onset and Severity of Retinopathy of Prematurity.

Nakazawa Y, Yasukawa T, Goto H, Kobayashi S, Yokoi K Diagnostics (Basel). 2025; 15(5).

PMID: 40075818 PMC: 11898616. DOI: 10.3390/diagnostics15050571.


Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis.

Silva B, Leal M, Farias M, Nava A, Galvan D, Fernandez E Front Immunol. 2025; 16:1505459.

PMID: 40018028 PMC: 11864942. DOI: 10.3389/fimmu.2025.1505459.


The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.

Li L, Zinger J, Sassen S, Juffermans N, Koch B, Endeman H Crit Care. 2024; 28(1):376.

PMID: 39563441 PMC: 11577668. DOI: 10.1186/s13054-024-05150-4.


Integrative omics analysis identifies biomarkers of septic cardiomyopathy.

Cai K, Luo Y, Chen H, Dong Y, Su Y, Lin C PLoS One. 2024; 19(11):e0310412.

PMID: 39546466 PMC: 11567565. DOI: 10.1371/journal.pone.0310412.


Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery.

Renzi S, Digiacomo L, Pozzi D, Quagliarini E, Vulpis E, Giuli M Nat Commun. 2024; 15(1):9119.

PMID: 39438484 PMC: 11496629. DOI: 10.1038/s41467-024-53569-8.